Sudarshan Singh Rathore - Infectious Diseases

Author Information

Sudarshan Singh Rathore is a researcher affiliated with the Actinomycetes Bioprospecting Lab at the Centre for Research in Infectious Diseases (CRID), which is part of the School of Chemical and Biotechnology at SASTRA University, located in Thanjavur, Tamilnadu, India. His research primarily focuses on infectious diseases, with a significant emphasis on microbial pathogens and their interactions with host immune responses.

Research Contributions

Dr. Sudarshan Singh Rathore has made substantial contributions to the field of infectious diseases, particularly in studying pathogens such as Cryptococcus neoformans and Klebsiella pneumoniae. His work encompasses both in vitro and in silico methodologies, including exploring novel inhibitors and compounds that exhibit antimicrobial and antibiofilm activities. Additionally, he has investigated the immunomodulatory potentials of various compounds, highlighting their roles in combating multi-drug-resistant pathogens. His research also delves into the non-medical use of antibiotics and its impact on clinical pathogen resistance.

Aliases

Throughout his academic career, Sudarshan Singh Rathore has been referred to by several aliases, including S. S. Rathore and Sudarshan S. Rathore. These variations appear across different publications and scientific contributions.

Publication and Citation Metrics

Metric	Value
Total Citations	188
H-index	9
Paper Count	23

Publications:

A holistic review on Cryptococcus neoformans.

DOI: 10.1016/j.micpath.2022.105521

Year: 2022

In vitro and in silico screening of Klebsiella pneumoniae new Delhi metallo-β-lactamase-1 inhibitors from endophytic Streptomyces spp.

DOI: 10.1080/07391102.2021.1990132

Year: 2021

Biofilm of Klebsiella Pneumoniae Minimize Phagocytosis and Cytokine Expression by Macrophage Cell Line

DOI: 10.21203/rs.3.rs-898502/v1

Year: 2021

Anti-Cryptococcal activity of a furanone derivative-antibiofilm and opsonophagocytic potential.

DOI: 10.1016/j.mycmed.2020.100924

Year: 2020

Biofilm of Klebsiella pneumoniae minimize phagocytosis and cytokine expression by macrophage cell line

DOI: 10.1101/623546

Year: 2019

Do Non-medical Uses of Antibiotics Develop Cross-Resistance in Clinical Pathogens?

DOI: 10.1007/978-981-13-8503-2_5

Year: 2019

Expression analysis of Cell wall invertase under abiotic stress conditions influencing specialized metabolism in Catharanthus roseus

DOI: 10.1038/s41598-018-33415-w

Year: 2018

ASK2 Bioactive Compound Inhibits MDR Klebsiella pneumoniae by Antibiofilm Activity, Modulating Macrophage Cytokines and Opsonophagocytosis

DOI: 10.3389/fcimb.2017.00346

Year: 2017

Potential Anticryptococcal Compound from Marine Nocardiopsis synnemataformans

DOI: 10.3923/JBS.2017.157.170

Year: 2017

Exploration of Antifungal and Immunomodulatory Potentials of a Furanone Derivative to Rescue Disseminated Cryptococosis in Mice

DOI: 10.1038/s41598-017-15500-8

Year: 2017

What is a Virus?

What Are the Limitations of Throat Swabs?

Is Fatigue a Long-term Issue in Infectious Diseases?

How Can Individuals and Communities Help in WHO’s Efforts?

What Are Prions and How Do They Cause Disease?

What is Schistosomiasis?

What is Ebola?

How Do Viruses Spread?

What is Co-Infection?

How Do Bacteria Become Resistant?

Partnered Content Networks

Relevant Topics